Viridian Therapeutics, Inc./DE Increase (Decrease) in Accounts Payable
Viridian Therapeutics, Inc./DE (VRDN) reported Increase (Decrease) in Accounts Payable of -$574.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$5.20M, a 212.37% decline year-over-year.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $4.63M, a 162.32% increase year-over-year.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.38M.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $1.55M, a 47.24% decline year-over-year.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts payable for fiscal 2025 was $6.56M.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts payable for fiscal 2024 was -$73.00K.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts payable for fiscal 2023 was -$12.04M, a 204.48% decline from fiscal 2022.
- Viridian Therapeutics, Inc./DE increase (decrease) in accounts payable for fiscal 2022 was $11.52M, a 596.31% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$5.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$574.00K 10-Q · filed 2026-08-06 | -$1.95M derived: sum of 3 quarters · filed 2026-08-06 | -$408.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $4.63M 10-Q · filed 2026-05-05 | $3.25M derived: sum of 2 quarters · filed 2026-05-05 | $4.80M derived: sum of 3 quarters · filed 2026-05-05 | $9.43M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $166.00K derived: sum of 2 quarters · filed 2026-02-26 | $4.80M derived: sum of 3 quarters · filed 2026-08-06 | $6.56M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $6.18M derived: sum of 2 quarters · filed 2026-08-06 | $7.94M 10-Q · filed 2025-11-05 | $4.02M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $4.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $6.40M 10-Q · filed 2026-08-06 | $2.47M derived: sum of 3 quarters · filed 2026-08-06 | $5.40M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $1.76M 10-Q · filed 2026-05-05 | -$2.16M derived: sum of 2 quarters · filed 2026-05-05 | $772.00K derived: sum of 3 quarters · filed 2026-05-05 | $1.21M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$993.00K derived: sum of 2 quarters · filed 2026-02-26 | -$555.00K derived: sum of 3 quarters · filed 2026-02-26 | -$73.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.37M derived: sum of 2 quarters · filed 2025-11-05 | $3.85M 10-Q · filed 2025-11-05 | $2.33M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $438.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $920.00K 10-Q · filed 2025-08-06 | -$596.00K derived: sum of 3 quarters · filed 2026-02-26 | -$704.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $482.00K 10-Q · filed 2025-05-06 | -$1.03M derived: sum of 2 quarters · filed 2026-02-26 | -$1.14M derived: sum of 3 quarters · filed 2026-02-26 | -$4.91M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.62M derived: sum of 2 quarters · filed 2026-02-26 | -$5.39M derived: sum of 3 quarters · filed 2026-02-26 | -$12.04M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$3.88M derived: sum of 2 quarters · filed 2024-11-12 | -$10.52M 10-Q · filed 2024-11-12 | -$8.78M derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | -$3.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$10.42M 10-Q · filed 2024-08-08 | -$8.67M derived: sum of 3 quarters · filed 2025-03-03 | -$624.00K derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | -$6.65M 10-Q · filed 2024-05-08 | -$26.00K 10-Q · filed 2023-05-10 | -$4.90M derived: sum of 2 quarters · filed 2025-03-03 | $3.15M derived: sum of 3 quarters · filed 2025-03-03 | $4.85M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $9.79M derived: sum of 2 quarters · filed 2025-03-03 | $11.49M derived: sum of 3 quarters · filed 2025-03-03 | $11.52M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $8.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $9.75M derived: sum of 2 quarters · filed 2023-11-13 | $9.78M 10-Q · filed 2023-11-13 | $8.37M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.73M 10-Q · filed 2023-08-08 | $326.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.79M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $31.00K 10-Q · filed 2023-05-10 | -$1.38M derived: sum of 2 quarters · filed 2024-02-27 | $85.00K derived: sum of 3 quarters · filed 2024-02-27 | -$1.03M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | -$1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $54.00K derived: sum of 2 quarters · filed 2024-02-27 | -$1.06M derived: sum of 3 quarters · filed 2024-02-27 | $1.66M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $346.00K derived: sum of 2 quarters · filed 2022-11-14 | $3.06M 10-Q · filed 2022-11-14 | $3.50M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.60M 10-Q · filed 2022-08-15 | $2.04M derived: sum of 3 quarters · filed 2022-08-15 | $1.99M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $2.71M 10-Q · filed 2022-05-13 | $3.15M derived: sum of 2 quarters · filed 2022-05-13 | $3.10M derived: sum of 3 quarters · filed 2022-05-13 | $1.88M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $438.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $384.00K derived: sum of 2 quarters · filed 2022-03-11 | -$836.00K derived: sum of 3 quarters · filed 2022-03-11 | -$426.00K 10-K · filed 2022-03-11 | |
| 2020-09-30 | -$54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$1.27M derived: sum of 2 quarters · filed 2021-11-05 | -$864.00K 10-Q · filed 2021-11-05 | -$1.32M derived: sum of 4 quarters · filed 2021-11-05 | |
| 2020-06-30 | -$1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$810.00K 10-Q · filed 2021-08-12 | -$1.27M derived: sum of 3 quarters · filed 2021-08-12 | -$946.00K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $410.00K 10-Q · filed 2021-05-07 | -$50.00K derived: sum of 2 quarters · filed 2021-05-07 | $274.00K derived: sum of 3 quarters · filed 2021-05-07 | $989.00K derived: sum of 4 quarters · filed 2021-05-07 | |
| 2019-12-31 | -$460.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | -$136.00K derived: sum of 2 quarters · filed 2021-03-26 | $579.00K derived: sum of 3 quarters · filed 2021-03-26 | $525.00K 10-K · filed 2021-03-26 | |
| 2019-09-30 | $324.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $1.04M derived: sum of 2 quarters · filed 2020-11-12 | $985.00K 10-Q · filed 2020-11-12 | $363.00K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $715.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $661.00K 10-Q · filed 2020-08-05 | $39.00K derived: sum of 3 quarters · filed 2020-08-05 | $771.00K derived: sum of 4 quarters · filed 2020-08-05 | |
| 2019-03-31 | -$54.00K 10-Q · filed 2020-05-08 | -$676.00K derived: sum of 2 quarters · filed 2020-05-08 | $56.00K derived: sum of 3 quarters · filed 2020-05-08 | -$243.00K derived: sum of 4 quarters · filed 2020-05-08 | |
| 2018-12-31 | -$622.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $110.00K derived: sum of 2 quarters · filed 2020-03-13 | -$189.00K derived: sum of 3 quarters · filed 2020-03-13 | -$335.00K 10-K · filed 2020-03-13 | |
| 2018-09-30 | $732.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $433.00K derived: sum of 2 quarters · filed 2019-11-08 | $287.00K 10-Q · filed 2019-11-08 | $784.00K derived: sum of 4 quarters · filed 2019-11-08 | |
| 2018-06-30 | -$299.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$445.00K 10-Q · filed 2019-08-08 | $52.00K derived: sum of 3 quarters · filed 2019-08-08 | -$148.00K derived: sum of 4 quarters · filed 2019-08-08 | |
| 2018-03-31 | -$146.00K 10-Q · filed 2019-05-09 | $351.00K derived: sum of 2 quarters · filed 2019-05-09 | $151.00K derived: sum of 3 quarters · filed 2019-05-09 | -$365.00K derived: sum of 4 quarters · filed 2019-05-09 | |
| 2017-12-31 | $497.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $297.00K derived: sum of 2 quarters · filed 2019-03-14 | -$219.00K derived: sum of 3 quarters · filed 2019-03-14 | -$101.00K 10-K · filed 2019-03-14 | |
| 2017-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$716.00K derived: sum of 2 quarters · filed 2018-11-07 | -$598.00K 10-Q · filed 2018-11-07 | $280.00K derived: sum of 4 quarters · filed 2018-11-07 | |
| 2017-06-30 | -$516.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$398.00K 10-Q · filed 2018-08-08 | $480.00K derived: sum of 3 quarters · filed 2018-08-08 | -$288.00K derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | $118.00K 10-Q · filed 2018-05-09 | $996.00K derived: sum of 2 quarters · filed 2018-05-09 | $228.00K derived: sum of 3 quarters · filed 2018-05-09 | $175.00K derived: sum of 4 quarters · filed 2018-05-09 | |
| 2016-12-31 | $878.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $110.00K derived: sum of 2 quarters · filed 2018-03-15 | $57.00K derived: sum of 3 quarters · filed 2018-03-15 | $292.00K 10-K · filed 2018-03-15 | |
| 2016-09-30 | -$768.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$821.00K derived: sum of 2 quarters · filed 2017-11-09 | -$586.00K 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | -$53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $182.00K 10-Q · filed 2017-08-11 | |||
| 2016-03-31 | $235.00K 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |